Credit Agricole
TXMD icon

Credit Agricole’s TherapeuticsMD TXMD Stock Holding History

Credit Agricole’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-818
Closed -$190K – 1623
2014
Q3 		$190K Buy
818
+79
+11% +$19.9K ﹤0.01% 1372
2014
Q2 		$163K Buy
739
+82
+12% +$18.2K ﹤0.01% 1409
2014
Q1 		$207K Buy
+657
New +$209K ﹤0.01% 1271

Other funds holding TXMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Credit Agricole's TXMD Position: Q4 2014 in Review

Credit Agricole sold out of TherapeuticsMD (TXMD) in Q4 2014, closing a stake of 818 shares — an estimated $190K sold.

Credit Agricole first reported a position in TXMD in Q1 2014 and held it in 3 quarters. The position peaked at $207K in Q1 2014. 81 funds tracked by Wall St. Rank hold TXMD as of Q4 2014.

  • Credit Agricole reported no remaining TherapeuticsMD position as of Q4 2014 after selling out during the quarter.
  • Credit Agricole sold 818 TherapeuticsMD shares in Q4 2014, an estimated $190K.
  • Credit Agricole first reported a position in TherapeuticsMD in Q1 2014 and held it in 3 quarters.
  • Credit Agricole's TherapeuticsMD position peaked at $207K in Q1 2014.
  • 81 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2014.

Based on Credit Agricole's 13F filing for Q4 2014, filed 9 Feb 2015.